Search Results

• Pathology Insights – Lung Cancer or Metastasis to Lung? with Sanjay Mukhopadhyay, MD

  Can metastases to the lung occur from cancers that were treated several years ago? Dr. Mukhopadhyay discusses.

• April 2018: Changes to Chemistry Tests

  Effective April 17, 2018, there will be changes to the build, reference ranges, and special/clinical information to several chemistry tests.

• Pathology Insights – Basics of Thymic Pathology with Sanjay Mukhopadhyay, MD

  What are the differences between normal thymic tissue and thymoma? Learn the basics in this brief overview with Sanjay Mukhopadhyay, MD.

• April 2018: Upcoming Test Changes

  Beginning in April 2018, there will be several test changes, discontinuations, and additions. Questions? Please contact Client Services.

• Pathology Insights – Challenging Cutaneous Spindle Cell Tumors with Steven Billings, MD

  Steven Billings, MD covers a set of challenging cutaneous spindle cell tumors, emphasizing a practical approach and key histologic features.

• Heparin Anti Xa Assay (HEPASY), PTT Incubated Mixing Study (PTTIM)

  Updates to Heparin Anti Xa Assay (HEPASY), PTT Incubated Mixing Study (PTTIM) testing are effective as of February 22, 2018.

• FLT3 Mutation Detection by PCR (FLT3MD)

  Effective February 5, 2018, FLT3 Mutation Detection by PCR (FLT3MD) testing will no longer accept specimens in a lithium heparin tube.

• February 2018: Polio Testing Update

  Effective on March 12, 2018, Poliovirus (Types 1, 3) Antibodies, IFA (POLIO) will be discontinued. We suggest ordering Polio Neutralization.

• December 2017: Changes to Chemistry Testing Go-Live Dates

  Due to unforeseen circumstances, the go-live dates for the following tests will be delayed until the indicated date.

• Pathology Insights – Atypical Epithelial Cells with Sanjay Mukhopadhyay, MD

  Sanjay Mukhopadhyay, MD discusses another unusual case of interstitial lung disease involving atypical epithelial cells.

• November 2017: Changes to Vitamin B12 (B12) Testing

  Effective December 7, 2017, Vitamin B12 (B12) Testing will include changes to ambient specimen stability and reference ranges.

• January 2018: Changes to Allergen Testing

  Effective January 4, 2018, changes to individual allergen and panel specimen volume, collection container, and stability will go into effect.

• Pathology Insights – Nonspecific Interstitial Pneumonia (NSIP) with Sanjay Mukhopadhyay, MD

  Sanjay Mukhopadhyay, MD explains the differences between Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia.

• Pathology Insights – Issues With Esophageal Biopsies with John Goldblum, MD

  In this episode, Dr. John Goldblum, Chair of Anatomic Pathology at Cleveland Clinic, discusses cases focused on Barrett's esophagus.

• Pathology Insights – Smoking-Related Interstitial Fibrosis with Sanjay Mukhopadhyay, MD

  Sanjay Mukhopadhyay, MD presents a case of a relatively recent form of interstitial fibrosis known as Smoking-Related Interstitial Fibrosis.

• Chromogranin A (CHROMA)

  Due to reagent shortage, Chromogranin A testing was recently discontinued. CCL will send testing to a different lab using a different assay.

• August 2017: Changes to Citrate, Urine 24 Hour (UCITD)

  Effective October 2, 2017, Citrate, Urine 24 Hour (UCITD) will incorporate changes affecting specimen stability and reference ranges.

• Pathology Insights – Orthopaedic Pathology: Osteoblastic Lesions with Scott Kilpatrick, MD

  Scott Kilpatrick, MD, Director of Orthopaedic Pathology, discusses osteoblastic lesions, which can be challenging to diagnose.

• Pathology Insights – Medical Kidney Pathology with Leal Herlitz, MD

  Dr. Leal Herlitz, Director of Medical Kidney Pathology, discusses an interesting renal pathology case received at Cleveland Clinic.

• Pathology Insights – Diagnosing Lung Cancer on Small Specimens with Jordan Reynolds, MD

  Dr. Jordan Reynolds discusses how pathologists at Cleveland Clinic diagnose lung cancer on small specimens.

• Pathology Insights – Well-Differentiated Lipomatous Tumors with John Goldblum, MD

  Dr. John Goldblum, Chair of Pathology at Cleveland Clinic, discusses one of the most common consults to the soft tissue pathology service.